These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35725977)

  • 1. Mapping the conformational energy landscape of Abl kinase using ClyA nanopore tweezers.
    Li F; Fahie MA; Gilliam KM; Pham R; Chen M
    Nat Commun; 2022 Jun; 13(1):3541. PubMed ID: 35725977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of a Randomized Sequence Scanning Approach in AlphaFold2 and Local Frustration Profiling of Conformational States Enable Interpretable Atomistic Characterization of Conformational Ensembles and Detection of Hidden Allosteric States in the ABL1 Protein Kinase.
    Raisinghani N; Alshahrani M; Gupta G; Tian H; Xiao S; Tao P; Verkhivker GM
    J Chem Theory Comput; 2024 Jun; 20(12):5317-5336. PubMed ID: 38865109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic view of the energy landscape in the allosteric regulation of Abl kinase.
    Saleh T; Rossi P; Kalodimos CG
    Nat Struct Mol Biol; 2017 Nov; 24(11):893-901. PubMed ID: 28945248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680.
    Young MA; Shah NP; Chao LH; Seeliger M; Milanov ZV; Biggs WH; Treiber DK; Patel HK; Zarrinkar PP; Lockhart DJ; Sawyers CL; Kuriyan J
    Cancer Res; 2006 Jan; 66(2):1007-14. PubMed ID: 16424036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2009 Aug; 5(8):e1000487. PubMed ID: 19714203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution.
    Tse A; Verkhivker GM
    PLoS One; 2015; 10(6):e0130203. PubMed ID: 26075886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.
    Hari SB; Perera BG; Ranjitkar P; Seeliger MA; Maly DJ
    ACS Chem Biol; 2013 Dec; 8(12):2734-43. PubMed ID: 24106839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation.
    Lovera S; Sutto L; Boubeva R; Scapozza L; Dölker N; Gervasio FL
    J Am Chem Soc; 2012 Feb; 134(5):2496-9. PubMed ID: 22280319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the autoinhibition of c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Young MA; Scheffzek K; Veach D; Bornmann W; Clarkson B; Superti-Furga G; Kuriyan J
    Cell; 2003 Mar; 112(6):859-71. PubMed ID: 12654251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric interactions between the myristate- and ATP-site of the Abl kinase.
    Iacob RE; Zhang J; Gray NS; Engen JR
    PLoS One; 2011 Jan; 6(1):e15929. PubMed ID: 21264348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved protonation-dependent switch controls drug binding in the Abl kinase.
    Shan Y; Seeliger MA; Eastwood MP; Frank F; Xu H; Jensen MØ; Dror RO; Kuriyan J; Shaw DE
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):139-44. PubMed ID: 19109437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transition between active and inactive conformations of Abl kinase studied by rock climbing and Milestoning.
    Narayan B; Fathizadeh A; Templeton C; He P; Arasteh S; Elber R; Buchete NV; Levy RM
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129508. PubMed ID: 31884066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.
    Cao X; Tanis KQ; Koleske AJ; Colicelli J
    J Biol Chem; 2008 Nov; 283(46):31401-7. PubMed ID: 18796434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
    Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
    Azam M; Nardi V; Shakespeare WC; Metcalf CA; Bohacek RS; Wang Y; Sundaramoorthi R; Sliz P; Veach DR; Bornmann WG; Clarkson B; Dalgarno DC; Sawyer TK; Daley GQ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9244-9. PubMed ID: 16754879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational disturbance in Abl kinase upon mutation and deregulation.
    Iacob RE; Pene-Dumitrescu T; Zhang J; Gray NS; Smithgall TE; Engen JR
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1386-91. PubMed ID: 19164531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.
    Welch PJ; Wang JY
    Mol Cell Biol; 1995 Oct; 15(10):5542-51. PubMed ID: 7565706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models.
    Meng Y; Gao C; Clawson DK; Atwell S; Russell M; Vieth M; Roux B
    J Chem Theory Comput; 2018 May; 14(5):2721-2732. PubMed ID: 29474075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.